Skip to content
(480) 999-0905
FacebookLinkedin
Arizona's Only Accredited Master Surgeon - Greg J. Marchand M.D.Arizona's Only Accredited Master Surgeon - Greg J. Marchand M.D.
Arizona's Only Accredited Master Surgeon – Greg J. Marchand M.D.
Arizona's Only Accredited Master Surgeon – Greg J. Marchand M.D.
  • Dr. Greg Marchand
    • About Dr. Marchand
    • Funding & Independence
  • Fellowship
  • Research
    • Publications
    • Research Methodology
    • Clinical Trials
    • Research Team
  • Newsroom
    • Press Kit
    • Expert Commentary
    • Media Coverage
    • Video Appearances
  • Collaborate
  • Contact
  • Dr. Greg Marchand
    • About Dr. Marchand
    • Funding & Independence
  • Fellowship
  • Research
    • Publications
    • Research Methodology
    • Clinical Trials
    • Research Team
  • Newsroom
    • Press Kit
    • Expert Commentary
    • Media Coverage
    • Video Appearances
  • Collaborate
  • Contact

Funding, Independence & Non-Profit Status

Dr. Greg Marchand’s research is not funded by industry. No pharmaceutical company, device manufacturer or commercial sponsor pays for, reviews, or has any right of approval over the systematic reviews and meta-analyses published under his name.

His research and educational work is carried out through the Marchand Institute for Minimally Invasive Surgery, a 501(c)(3) tax-exempt non-profit research and educational corporation in Mesa, Arizona (EIN 42-2857240), which he founded and directs. This page sets out that structure, the funding position, the preferred affiliation statement for co-authors and editors, his verified researcher identifiers, and where to find him this year.

Mission

The Institute exists to make gynecologic surgery less invasive, better evidenced and more widely available. Dr. Marchand pursues that through three activities: producing rigorous systematic reviews and meta-analyses that answer questions surgeons actually face; training surgeons through an accredited fellowship and simulation program; and developing and evaluating surgical techniques and instrumentation that reduce incision size, pain, recovery time and complications.

His founding commitment is that these advances should reach all women, regardless of nationality, economic class or ability to pay.

Non-Profit Status

The Marchand Institute for Minimally Invasive Surgery is a not-for-profit research and educational corporation based in Mesa, Arizona, and is recognized by the United States Internal Revenue Service as exempt from federal income tax under Internal Revenue Code section 501(c)(3).

Legal name Marchand Institute for Minimally Invasive Surgery
Employer Identification Number (EIN) 42-2857240
Exempt status Exempt from federal income tax under IRC section 501(c)(3)
IRS classification Private foundation within the meaning of IRC section 509(a)
Effective date of exemption 29 May 2026
Annual return filed IRS Form 990-PF (Return of Private Foundation), filed annually
Accounting period ends 31 December
Registered address 10238 E. Hampton Ave., Suite 212, Mesa, Arizona 85209, USA

Contributions to the Institute are deductible by donors under IRC section 170, and the Institute is qualified to receive tax-deductible bequests, devises, transfers and gifts under sections 2055, 2106 and 2522. Journalists, editors and grant administrators can confirm all of the above independently through the IRS Tax Exempt Organization Search using the EIN above.

No part of the Institute’s net earnings inures to the benefit of any private shareholder or individual. Surplus from any activity is applied to the Institute’s research and educational programs. A copy of the IRS determination letter is available to media and prospective collaborators on request.

Funding and Independence

Dr. Marchand accepts no outside funding for his research program.

Dr. Marchand’s systematic reviews and meta-analyses are not supported by pharmaceutical companies, medical device manufacturers, professional societies, advocacy organizations or any other external sponsor. Neither he nor his investigators hold consulting agreements, advisory board fees, speaking fees, equity positions or royalty arrangements with pharmaceutical or medical device companies. Dr. Marchand openly declares no conflicts of interest.

Because there is no sponsor, there is no sponsor influence. No outside party selects his research questions, defines his comparators, reviews his manuscripts before submission, or has any right of approval over what he publishes. He publishes null results and results unfavorable to popular or commercially promoted techniques, and has done so repeatedly.

Dr. Marchand’s only institutional affiliations are with the participating hospitals of his fellowship program. Where he participates as a clinical trial site principal investigator, that work is compensated at fair market value for clinical services performed under a sponsor’s protocol; it is separate from, and does not fund, his research program.

Dr. Marchand does not solicit public donations. If that changes, it will be stated plainly on this page.

Preferred Affiliation Statement

To keep this output correctly aggregated in PubMed, Scopus and Web of Science, authors publishing work performed at or with the Institute should use the following affiliation string exactly.

Marchand Institute for Minimally Invasive Surgery, Mesa, Arizona, USA

Where a journal requires a full postal affiliation:

Marchand Institute for Minimally Invasive Surgery, 10238 E. Hampton Ave., Suite 212, Mesa, AZ 85209, USA

Fellows and trainees should additionally list:

Fellowship in Minimally Invasive and Robotic Gynecologic Surgery, HonorHealth Four Peaks Medical Center, Mesa, AZ, USA

Please do not use shortened or alternative forms such as “Marchand Institute”, “The Marchand Institute, AZ”, “Marchand OBGYN” or “Marchand Institute of Minimally Invasive Surgery” (note: for, not of). Inconsistent strings fragment the indexed record and undercount institutional output. Systematic review protocols should be registered with PROSPERO under the same organizational name.

Researcher Identifiers

Persistent identifiers for Greg J. Marchand, MD, FACS, FACOG, FICS:

ORCID iD 0000-0003-4724-9148
Google Scholar Gregory Marchand — Google Scholar profile (verified email at marchandinstitute.org)
Scopus Author ID 57216591264
Web of Science ResearcherID AAG-7878-2021
ResearchGate Greg Marchand — ResearchGate profile
SciProfiles (MDPI) 2533203
PubMed collection All indexed Marchand Institute work in PubMed
PROSPERO 65 systematic review protocols registered under his research program; 41 with Dr. Marchand as named contact. Search the PROSPERO register.
Institute publication database All 137 works with DOI and PMID · RSS feed

Dr. Marchand is a verified peer reviewer through the Web of Science Reviewer Recognition Service and ORCID, and an NIH Early Stage Investigator.

Research Impact

Citations 1,200+ (Google Scholar); 702 (Scopus); 641 (Web of Science Core Collection)
h-index 18 (Google Scholar); 15 (Scopus); 15 (Web of Science)
i10-index 26 (Google Scholar)
Indexed documents 137 total; 97 peer-reviewed articles
Most cited work Birth outcomes of neonates exposed to marijuana in utero: a systematic review and meta-analysis. JAMA Network Open. 2022;5(1):e2145653
Second most cited Systematic review and meta-analysis of COVID-19 maternal and neonatal clinical features and pregnancy outcomes. AJOG Global Reports. 2022;2(1):100049

Metrics verified August 2026.

Where to Find Dr. Marchand This Year

  • AAGL 2026 Global Congress — 55th Global Congress on Minimally Invasive Gynecologic Surgery, Boston, Massachusetts, November 13–16, 2026. Presenting on surgical treatment of adnexal masses in pediatric patients, and on miniature laparoscopy versus single-port laparoscopy in hysterectomy.
  • SLS Minimally Invasive Surgery Week 2026 (MISWeek) — DoubleTree by Hilton at the Entrance to Universal Orlando, Orlando, Florida, December 2–5, 2026. Oral presentation of his Bulkamid systematic review for female stress urinary incontinence on December 3, 2026.

Colleagues, prospective fellows and members of the press are welcome to find Dr. Marchand at either meeting. Email maria@marchandobgyn.com to arrange a time.

Contact

Marchand Institute for Minimally Invasive Surgery
10238 E. Hampton Ave., Suite 212, Mesa, Arizona 85209, USA
Telephone (480) 999-0905 · Fax (480) 999-0801

Research and academic inquiries: Propose a Collaboration
Media inquiries: Newsroom and Press Kit

Articles
  • American Journal of Obstetrics & Gynecology MFM (AJOG MFM) journal cover
    Fresh Off the Press in AJOG MFM: Marchand Institute’s New Meta-Analysis on Single- vs. Double-Layer Uterine Closure and Cesarean Scar Outcomes
    July 28, 2026
  • New Research from Dr. Greg Marchand: Evaluating the Impact of Robotic Assistance in Single-Site Hysterectomy
    February 20, 2026
  • Exciting News: Dr. Marchand’s Latest Meta-Analysis on Opportunistic Salpingectomy for Epithelial Ovarian Cancer Prevention is Published and Open Access!
    February 5, 2026
  • New Systematic Review and Meta-Analysis: Comparative Risk of Neonatal Ischemic Encephalopathy in Operative Vaginal Delivery vs. Cesarean at Complete Dilation – Now Online in AJP!
    January 29, 2026
  • We're thrilled to announce the publication of a groundbreaking systematic review and meta-analysis led by Dr. Greg Marchand and the dedicated research team at the Marchand Institute for Minimally Invasive Surgery! Titled "Laparoendoscopic Single-Site Surgery Versus Conventional Laparoscopic Surgery in Ovarian Cystectomy: A Meta-Analysis", this comprehensive study compares two advanced minimally invasive techniques for removing benign ovarian cysts — Laparoendoscopic Single-Site Surgery (LESS) (using a single small incision, often hidden at the umbilicus for superior cosmetic results) and Conventional Laparoscopic Surgery (CLS) (using multiple small incisions). Analyzing data from 9 studies involving 1,368 women, the meta-analysis reveals compelling insights: LESS is associated with longer operative times (by about 9.4 minutes on average), likely due to the technical demands of working through a single port. However, patients undergoing LESS benefit from a shorter hospital stay (reduced by approximately 0.26 days). Importantly, there are no significant differences in key safety outcomes: postoperative pain scores (at 6 and 24 hours), estimated blood loss, need for opioid analgesics, drop in hemoglobin levels, or overall complication rates. These findings strengthen the evidence that LESS is a safe, effective, and viable alternative to conventional laparoscopy for women with benign ovarian cysts — offering faster recovery and excellent cosmetic advantages while maintaining comparable safety and pain profiles. This work adds valuable high-level evidence to the field of minimally invasive gynecologic surgery and reflects the Marchand Institute's ongoing commitment to advancing women's health through rigorous, volunteer-driven research. Read the full open-access paper for free today: PubMed Central (PMC) (recommended - full text & PDF): https://pmc.ncbi.nlm.nih.gov/articles/PMC12734174/ Direct PDF download: https://pmc.ncbi.nlm.nih.gov/articles/PMC12734174/pdf/jcm-14-08739.pdf Published in Journal of Clinical Medicine (December 10, 2025) – DOI: 10.3390/jcm14248739 We invite clinicians, researchers, and patients interested in the latest advancements in minimally invasive surgery to explore this important contribution. A huge thank you to our incredible team of researchers, students, and collaborators who made this possible — all volunteer efforts dedicated to improving outcomes for women everywhere! Visit us at marchandinstitute.org to learn more about our ongoing research, educational programs, and mission to push the boundaries of minimally invasive techniques.
    Newest Paper on Laparoscopic Single Site Ovarian Cystectomy Online Now!
    January 1, 2026
  • New Systematic Review Reveals Gynecologic Surgeons Achieve Superior Outcomes in Pediatric Adnexal Mass Surgery – Now Freely Available Online!
    December 18, 2025
What patients say
  • 14517468_1646198135690553_6990924301147850409_n“I delivered both my beautiful babies with Dr. Marchand and I wouldn’t have it any other way! Every doctor visit up until I was in labor was great, he took all the time to answer all my questions. I didn’t feel rushed in and rushed out of the office. The office was always very clean! The staff were always very friendly. When I was in labor he made sure my birth plan was the most important thing! He always had my best interest in hand! My first delivery I was induced and it took 3 long days and Marchand kept checking on me all hours of the night!! If I did it all over again I’d definitely use Marchand as my OB again!”

    Alex S.
  • “We congratulate Dr. Greg J. Marchand as SRC’s first Surgeon of Excellence in Minimally Invasive Surgery (SOEMIS) in the United States. To achieve SOEMIS accreditation, Dr. Marchand invited SRC to complete a rigorous onsite inspection and thorough chart review to illustrate his compliance with the program. Dr. Marchand and his practice exemplify SRC’s commitment to patient safety and care.”

    Ashley DuBray, Senior Director of the Surgical Review Corporation
  • “I initially met Dr. Marchand upon an emergency room visit due to complications during my first pregnancy. My husband and I had recently moved from out of state. Not knowing many people here, in a scary situation and finding myself hospitalized was made a lot easier once we met Dr. Marchand who we decided would be the best doctor to see my care through the pregnancy and ultimate c-section. He always had time for our questions even when we knew he had many other patients. He did a great job with the surgery and follow up care and was very pleasant, patient and professional throughout the process. When we decided to have another baby, he saw us through another pregnancy and c-section and continues to be my OB of choice. I would recommend him in a heartbeat to any girlfriends I know.”

    Megan E. of Gilbert, AZ
  • “Growing up I have had my fair share of woman health issue from Endometriosis, PCOS, Severe Pelvic Pain, Loss of Pregnancy and Infertility and more pelvic surgeries than I can count. I have seen many different doctors till about 6-7 years ago when I needed emergency surgery and met Dr. Marchand and now I refuse to go to any one else. With the many issues I have had both Dr. Marchand as well as his whole office staff have been so helpful I couldn’t be more grateful. It’s very hard to find an honest, trustworthy doctor these days but rest assured you can’t go wrong with Dr. Greg Marchand. They are open late and almost always can fit you into the schedule for emergencies and you can always reach him no matter what time it is if you have questions. Dr. Marchand is an amazing surgeon and loves what he does. He has delivered many friends and family’s children and hope that one day he will be able to deliver mine as well.”

    Tomi M. of Gilbert
Arizona's Only Accredited Master Surgeon - Greg J. Marchand M.D.
© Greg Marchand MD

Loading Comments...

Research repository

Every paper, abstract and presentation Dr. Marchand publishes is listed in his open research repository. Subscribe by RSS to be notified whenever new work is added.

Browse the repository All research (RSS)

Topic feeds: Peer-reviewed articles | Conference presentations